Insulet Corporation (BMV:PODD)

Market Cap	296.86B -25.3%
Revenue (ttm)	46.26B +27.1%
Net Income	4.52B -41.5%
EPS	63.30 -39.8%
Shares Out	n/a
PE Ratio	65.74
Forward PE	42.05
Dividend	n/a
Ex-Dividend Date	n/a

Volume	6
Average Volume	185
Open	4,402.00
Previous Close	n/a
Day's Range	4,402.00 - 4,402.00
52-Week Range	4,402.00 - 6,170.25
Beta	n/a
RSI	44.69
Earnings Date	Feb 18, 2026

About Insulet

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; and Omnipod DASH insulin management system that features a Bluetooth enabled pod that is cont...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 2000
• Employees: 3,900
• Stock Exchange: Mexican Stock Exchange
• Ticker Symbol: PODD

Financial Performance

In 2024, Insulet's revenue was $2.07 billion, an increase of 22.07% compared to the previous year's $1.70 billion. Earnings were $418.30 million, an increase of 102.76%.

Financial numbers in USD